Exosomes News and Research

RSS

Scientists reveal unexpected route to slow progression of diabetic kidney disease

More than 660,000 people in the United States suffer from end-stage kidney disease, which can only be treated by dialysis or kidney transplantation. Almost half of these patients develop the condition as a complication of diabetes.

25 Apr 2017

Research shows potential way to limit damage to the brain caused by seizure disorder

Tiny vesicles isolated from adult mesenchymal stem cells and administered intranasally can limit the damage to the brain of animal models caused by a seizure disorder called status epilepticus, according to research published this week in the Proceedings of the National Academy of Sciences.

21 Apr 2017

Researchers reveal immune machinery that goes awry to trigger neutrophilic dermatosis

A research team led by St. Jude Children's Research Hospital immunologists has revealed a previously unknown immune machinery that goes awry to trigger the inflammatory disease neutrophilic dermatosis.

18 Apr 2017

Research finding could offer new way to fight deadly pancreatic cancer

Pancreatic cancer, most frequently pancreatic ductal adenocarcinoma (PDAC), is the most lethal and aggressive of all cancers. Unfortunately, there are not many effective therapies available other than surgery, and that is not an option for many patients.

10 Apr 2017

Organoids in cell culture dish offer new insights into development of the brain

A new method could push research into developmental brain disorders an important step forward. This is shown by a recent study at the University of Bonn in which the researchers investigated the development of a rare congenital brain defect.

4 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN N.V. today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer.

From QIAGEN Manchester Limited 31 Mar 2017

New fluorescent probe could illuminate tumors during surgery

What if you could plaster cancer cells with glowing "Here We Are" signs, so surgeons could be confident that they'd removed every last speck of a tumor? That's what Haiying Liu has in mind for his new fluorescent probe.

28 Mar 2017

Disease of antiquity: University of Notre Dame expert focuses on tuberculosis research

In the time it takes to read this article, half a dozen people will have died from tuberculosis. It is a cruel and persistent killer, claiming 1.8 million lives each year, an estimated 200,000 of which are children, according to the World Health Organization.

27 Mar 2017

New technology may provide non-invasive approach to diagnose and monitor prostate cancer

Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease's progression.

22 Mar 2017

Simple blood test may soon eliminate need for invasive procedures to detect, monitor cancer

Doctors may soon be able to detect and monitor a patient's cancer with a simple blood test, reducing or eliminating the need for more invasive procedures, according to Purdue University research.

21 Mar 2017

Penn scientists discover method that appears to provide early warning of transplant rejection

Approximately 30,000 organ transplants occur in the United States each year. However, between 20 and 50 percent—depending on the organ type—of the transplanted organs fail within five years, most often because the recipient's immune system attacks, or "rejects," the donated organ.

21 Mar 2017

AXT introduces super-resolution fluorescence microscope capable of single molecule imaging in Australia and NZ

AXT are proud to announce that they have recently been appointed the exclusive Australian and New Zealand distributor for Oxford Nanoimaging (ONI). ONI is a UK-based company that has commercialised the “Nanoimager” a revolutionary super-resolution fluorescence microscope capable of single molecule imaging.

From AXT Pty Ltd 21 Mar 2017

Better understanding of pre-metastatic niches could lead to new preventive therapies

Metastasis is the major cause of cancer-related death and its appearance remains a phenomenon that is difficult to predict and manage.

17 Mar 2017

Researchers use Syngene’s G:BOX Chemi XRQ image analysis system in cardiac research

Syngene, a world-leading manufacturer of image analysis solutions is delighted to announce that the G:BOX Chemi XRQ high resolution, multi-application image analysis system is being successfully used at the Lithuanian University of Health Sciences Academy of Medicine to study molecular mechanisms of cardiac stem cell function which could help in developing stem cell therapies for heart repair.

From Syngene 17 Mar 2017

The Sohn Conference Foundation funds research to advance understanding of how pediatric cancer metastasizes

The Sohn Conference Foundation today unveiled the Sohn Collaborative for Liquid Biopsy at Weill Cornell Medicine to develop a blood test that will predict how cancer spreads in both children and adults.

17 Mar 2017

Research shows how Ebola viral proteins packaged in exosomes affect immune cells

Cells infected by the deadly Ebola virus may release viral proteins such as VP40 packaged in exosomes, which, as new research indicates, can affect immune cells throughout the body impairing their ability to combat the infection and to seek out and destroy hidden virus.

16 Mar 2017

Exosomes News and Research

Scientists reveal unexpected route to slow progression of diabetic kidney disease

Research shows potential way to limit damage to the brain caused by seizure disorder

Researchers reveal immune machinery that goes awry to trigger neutrophilic dermatosis

Research finding could offer new way to fight deadly pancreatic cancer

Organoids in cell culture dish offer new insights into development of the brain

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

New fluorescent probe could illuminate tumors during surgery

Disease of antiquity: University of Notre Dame expert focuses on tuberculosis research

New technology may provide non-invasive approach to diagnose and monitor prostate cancer

Simple blood test may soon eliminate need for invasive procedures to detect, monitor cancer

Penn scientists discover method that appears to provide early warning of transplant rejection

AXT introduces super-resolution fluorescence microscope capable of single molecule imaging in Australia and NZ

Better understanding of pre-metastatic niches could lead to new preventive therapies

Researchers use Syngene’s G:BOX Chemi XRQ image analysis system in cardiac research

The Sohn Conference Foundation funds research to advance understanding of how pediatric cancer metastasizes

Research shows how Ebola viral proteins packaged in exosomes affect immune cells

Researchers make surprising and crucial discovery about Alexander disease

Natural immune molecule shows protective effect against Zika virus in mouse, monkey models

Researchers develop new platform for culturing pluripotent stem cells

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms